- Home
- CELC vs CWBC Comparison
CELC vs CWBC Comparison
Compare CELC & CWBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELC
- CWBC
- Stock Information
- Founded
- CELC 2011
- CWBC 1989
- Country
- CELC United States
- CWBC United States
- Employees
- CELC N/A
- CWBC N/A
- Industry
- CELC Medical Specialities
- CWBC Major Banks
- Sector
- CELC Health Care
- CWBC Finance
- Exchange
- CELC Nasdaq
- CWBC Nasdaq
- Market Cap
- CELC 391.0M
- CWBC 342.9M
- IPO Year
- CELC 2017
- CWBC 1996
- Fundamental
- Price
- CELC $10.11
- CWBC $18.48
- Analyst Decision
- CELC Strong Buy
- CWBC Buy
- Analyst Count
- CELC 6
- CWBC 3
- Target Price
- CELC $30.17
- CWBC $23.33
- AVG Volume (30 Days)
- CELC 248.4K
- CWBC 51.6K
- Earning Date
- CELC 03-31-2025
- CWBC 04-17-2025
- Dividend Yield
- CELC N/A
- CWBC 2.59%
- EPS Growth
- CELC N/A
- CWBC N/A
- EPS
- CELC N/A
- CWBC 0.45
- Revenue
- CELC N/A
- CWBC $105,699,000.00
- Revenue This Year
- CELC $49.98
- CWBC $32.09
- Revenue Next Year
- CELC N/A
- CWBC $6.44
- P/E Ratio
- CELC N/A
- CWBC $41.28
- Revenue Growth
- CELC N/A
- CWBC 18.58
- 52 Week Low
- CELC $8.53
- CWBC $15.50
- 52 Week High
- CELC $22.04
- CWBC $24.47
- Technical
- Relative Strength Index (RSI)
- CELC 43.41
- CWBC 49.52
- Support Level
- CELC $9.98
- CWBC $17.97
- Resistance Level
- CELC $10.70
- CWBC $18.90
- Average True Range (ATR)
- CELC 0.68
- CWBC 0.43
- MACD
- CELC 0.06
- CWBC 0.07
- Stochastic Oscillator
- CELC 28.38
- CWBC 61.82
About CELC Celcuity Inc.
Celcuity Inc is a clinical-stage biotechnology company pursuing development for oncology. The Company's lead therapeutic candidate is gedatolisib, a potent pan-PI3K and mTOR inhibitor. Its mechanism of action and pharmacokinetic properties are highly differentiated from other currently approved and investigational therapies that target PI3K or mTOR alone or together. A Phase 3 clinical trial, VIKTORIA-1, evaluating gedatolisib in combination with fulvestrant with or without palbociclib in patients with HR+/HER2- advanced breast cancer is currently enrolling patients.
About CWBC Community West Bancshares
Community West Bancshares is a bank holding company whose principal business is to serve as the holding company for its wholly-owned subsidiary Community West Bank N.A. Through CWB, the Company provides a variety of financial products and full-service Banking Centers within California's Greater Sacramento, San Joaquin Valley, and Central Coast regions, that provide Commercial Lending, Real Estate, Agribusiness, Private Banking, and Cash Management Departments.